Vascular Anomalies of the Head and Neck: A Review of Genetics

References

• Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982 Mar;69(3):412–422
   PubMed Web of Science ®Google Scholar
• Mehta M, Salas AH, Fay A. Trigeminal dermatome distribution in patients with glaucoma and facial port wine stain. Dermatology 2009;219(3):219–224
   PubMedGoogle Scholar
• Rydy M, Malm M, Jernbeck J, Dalsgaard C. Ectatic blood vessels in port wine stains lack innervation: Possible role in pathogenesis. Plast Reconstr Surg 1991;87:419
   PubMedGoogle Scholar
• Frigerio A, Stevenson DA, Grimmer JF. The genetics of vascular anomalies. Curr Opin Otolaryngol Head Neck Surg 2012 Dec;20(6):527–532
   PubMedGoogle Scholar
• Berenstein A, Ortiz R, Niimi Y, et al. Endovascular management of arteriovenous malformations and other intracranial arteriovenous shunts in neonates, infants, and children. Childs Nerv Syst 2010 Oct;26(10):1345–1358
   PubMedGoogle Scholar
• Breugem CC, Alders M, Salieb-Beugelaar GB, et al. A locus for hereditary capillary malformations mapped on chromosome 5q. Hum Genet 2002;110:343–347
   PubMed Web of Science ®Google Scholar
• Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003;73:1240–1249
   PubMed Web of Science ®Google Scholar
• Boon LM, Mulliken JB, Vikkula M. RASA1: Variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 2005;15:265–269
   PubMed Web of Science ®Google Scholar
• Wooderchak-Donahue W, Stevenson DA, McDonald J, et al. RASA1 analysis: Clinical and molecular findings in a series of consecutive cases. Eur J Med Genet 2012;55:91–95
   PubMedGoogle Scholar
• Revencu N, Boon LM, Mulliken JB, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 2008;29:959–965
   PubMed Web of Science ®Google Scholar
• Henkemeyer M, Rossi DJ, Holmyard DP, et al. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 1995;377:695–701
   PubMed Web of Science ®Google Scholar
• Kulkarni SV, Gish G, van der Geer P, et al. Role of p120 Ras-GAP in directed cell movement. J Cell Biol 2000;149:457–470
   PubMed Web of Science ®Google Scholar
• Boon LM, Mulliken JB, Vikkula M. RASA1: Variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 2005;15:265–269
   PubMed Web of Science ®Google Scholar
• Boon LM, Ballieux F, Vikkula M. Pathogenesis of vascular anomalies. Clin Plast Surg 2011;38:7–19
   PubMedGoogle Scholar
• Thiex R, Mulliken JB, Revencu N, et al. A novel association between RASA1mutations and spinal arteriovenous anomalies. AJNR Am J Neuroradiol 2010;31:775–779
   PubMed Web of Science ®Google Scholar
• Brancati F, Valente EM, Tadini G, et al. Autosomal dominant hereditary benign telangiectasia maps to the CMC1 locus for capillary malformation on chromosome 5q14. J Med Genet 2003;40:849–853
   PubMedGoogle Scholar
• Onal H, Adal E, Ersen A, Onal Z. Turner syndrome with a ring X chromosome and atypical skin manifestation: Port wine stain. Int J Dermatol 2012;51:207–210
   PubMedGoogle Scholar
• Sanchez-Carpintero I, Mihm MC, Mizeracki A, et al. Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: Morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol 2004; 50:608–612
   PubMed Web of Science ®Google Scholar
• Blinkenberg EO, Brendehaug A, Sandvik AK, et al. Angioma serpiginosum with oesophageal papillomatosis is an X-linked dominant condition that maps to Xp11.3-Xq12. Eur J Hum Genet 2007;15:543–547
   PubMedGoogle Scholar
• Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3:331–333
   PubMedGoogle Scholar
• Fay A, Rodgers IR. Vascular anomalies of the eyelid and the orbit. Albert & Jakobiec’s, Principles and Practice of Ophthalmology, 3rd ed., Vol. 3, Chapter 235, 2008, 3005–3018
   Google Scholar
• Grimmer JF, Williams MS, Pimentel R, et al. Hemangioma is associated with & atopic disease. Otolaryngol Head Neck Surg 2012;146:206–209
   PubMedGoogle Scholar
• Grimmer JF, Williams MS, Pimentel R, et al. Familial clustering of hemangiomas. Arch Otolaryngol Headn Neck Surg 2011;137:757–760
   PubMedGoogle Scholar
• Walter JW, Blei F, Anderson JL, et al. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 1999;82:77–83
   PubMedGoogle Scholar
• Mitchell S, Siegel DH, Shieh JT, et al. Candidate locus analysis for PHACE & syndrome. Am J Med Genet A 2012;158A:1363–1367
   PubMedGoogle Scholar
• Bischoff J. Progenitor cells in infantile hemangioma. J Craniofac Surg 2009;20(Suppl 1):695–697
   PubMedGoogle Scholar
• Boye E, Yu Y, Paranya G, et al. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001;107:745–752
   PubMed Web of Science ®Google Scholar
• Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 2008;14:1236–1246
   PubMed Web of Science ®Google Scholar
• Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet 2003 Apr 1;12 Spec No 1:R9–13
   Google Scholar
• Wu JK, Adepoju O, De Silva D, et al. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma. Angiogenesis 2010;13:15–23
   PubMedGoogle Scholar
• Boscolo E, Stewart CL, Greenberger S, et al. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 2011;31:2181–2192
   Google Scholar
• Greenberger S, Adini I, Boscolo E, et al. Targeting NF-kappaB in infantile hemangioma-derived stem cells reduces VEGF-A expression. Angiogenesis 2010;13:327–335
   PubMed Web of Science ®Google Scholar
• Waner M, Suen JY. Hemangiomas and Vascular Malformations of the Head and Neck, 1st ed.; New York: Wiley-Liss, 1999;5–50
   Google Scholar
• Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45–67
   PubMed Web of Science ®Google Scholar
• Malone FD, Berkowitz RL, Canick JA, et al. First-trimester screening for aneuploidy: Research or standard of care? Am J Obstet Gynecol 2000;182:490–496
   PubMedGoogle Scholar
• Moscoso G. Fetal nuchal translucency: A need to understand the physiological basis. Ultrasound Obstet Gynecol 1995;5:6–8
   PubMedGoogle Scholar
• Gedikbasi A, Oztarhan K, Yararbas K, et al. Prenatal diagnsis of intracardiac hamartoma and Turner syndrome. Fetal Pediatr Pathol 2010;29:330–337
   PubMed Web of Science ®Google Scholar
• Bakker M, Pajkrt E, Mathijssen IB, Bilardo CM. Targeted ultrasound examination and DNA testing for Noonan syndrome, in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn 2011;31:833–840
   PubMed Web of Science ®Google Scholar
• Ghalamkarpour A, Holnthoner W, Saharinen P, et al. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. J Med Genet 2009;46:399–404
   PubMedGoogle Scholar
• Irrthum A, Karkkainen MJ, Devriendt K, et al. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 2000;67:295–301
   PubMedGoogle Scholar
• Irrthum A, Devriendt K, Chitayat D, et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J Hum Genet 2003;72:1470–1478
   PubMed Web of Science ®Google Scholar
• Connell F, Kalidas K, Ostergaard P, et al. Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia. Hum Genet 2010;127:231–241
   PubMed Web of Science ®Google Scholar
• Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet 2007;16 (Spec No 2):R140
   Google Scholar
• Limaye N, Wouters V, Uebelhoer M, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 2009;41:118
   PubMed Web of Science ®Google Scholar
• Boon LM, Mulliken JB, Enjolras O, et al. Glomuvenous malformation (glomangioma) and venous malformation: Distinct clinicopathologic and genetic entities. Arch Dermatol 2004;140:971
   PubMedGoogle Scholar
• Boon LM, Mulliken JB, Vikkula M, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 1994;3:1583–1587
   PubMedGoogle Scholar
• Gallione CJ, Pasyk KA, Boon LM, et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet 1995;32:197–199
   PubMed Web of Science ®Google Scholar
• Wouters V, Limaye N, Uebelhoer M, et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet 2010;18:414–420
   PubMedGoogle Scholar
• Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 2006;312:630–641
   PubMed Web of Science ®Google Scholar
• Hu HT, Huang YH, Chang YA, et al. Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression. J Invest Dermatol 2008;128:2325–2333
   PubMedGoogle Scholar
• Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol 2004;140:971–976
   PubMedGoogle Scholar
• Boon LM, Brouillard P, Irrthum A, et al. A gene for inherited cutaneous venous anomalies (“glomangiomas”) localizes to chromosome 1p21–22. Am J Hum Genet 1999;65:125–133
   PubMedGoogle Scholar
• Brouillard P, Boon LM, Mulliken JB, et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”). Am J Hum Genet 2002;70:866–874
   PubMed Web of Science ®Google Scholar
• Vikkula M, Boon LM, Carraway KL 3rd, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181–1190
   PubMed Web of Science ®Google Scholar
• Revencu N, Vikkula M. Cerebral cavernous malformation: New molecular and clinical insights. J Med Genet 2006;43:716
   PubMed Web of Science ®Google Scholar